COST-EFFECTIVENESS OF STATIN PRIORITISATION BASED ON ABSOLUTE RISK REDUCTION FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE

被引：0
|
作者：
Kohli-Lynch, C. N. [1 ]
Moran, A. E. [1 ]
Thanassoulis, G. [2 ]
Sniderman, A. D. [2 ]
Zhang, Y. [1 ]
Pencina, M. [3 ]
Pletcher, M. J. [4 ]
Vittinghoff, E. [4 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] McGill Univ, Quebec City, PQ, Canada
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1223
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV77
引用
收藏
页码：A614 / A614
页数：1
相关论文
共 50 条
  • [1] CARDIOVASCULAR GENETIC RISK TESTING FOR TARGETING STATIN THERAPY IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: A COST-EFFECTIVENESS ANALYSIS
    Jarmul, Jamie A.
    Pletcher, Mark J.
    Earnshaw, Stephanie
    Weinberger, Morris
    Jonas, Daniel
    Avery, Christy
    Lich, Kristen Hassmiller
    Wheeler, Stephanie
    Pignone, Michael
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S133 - S134
  • [2] Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Cost-Effectiveness Analysis
    Jarmul, Jamie
    Pletcher, Mark J.
    Lich, Kristen Hassmiller
    Wheeler, Stephanie B.
    Weinberger, Morris
    Avery, Christy L.
    Jonas, Daniel E.
    Earnshaw, Stephanie
    Pignone, Michael
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (04):
  • [3] Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
    Pandya, Ankur
    Sy, Stephen
    Cho, Sylvia
    Weinstein, Milton C.
    Gaziano, Thomas A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02): : 142 - 150
  • [4] Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention
    Kiflen, Michel
    Le, Ann
    Mao, Shihong
    Lali, Ricky
    Narula, Sukrit
    Xie, Feng
    Pare, Guillaume
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2022, 15 (05): : 386 - 395
  • [5] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [6] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [7] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    [J]. CIRCULATION, 2004, 110 (17) : 802 - 802
  • [8] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [9] Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
    Lin, Liang
    Teng, Monica
    Zhao, Ying Jiao
    Khoo, Ai Leng
    Seet, Raymond Chee Seong
    Yong, Quek Wei
    Yeo, Tiong Cheng
    Lim, Boon Peng
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 187 - 197
  • [10] Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
    Liang Lin
    Monica Teng
    Ying Jiao Zhao
    Ai Leng Khoo
    Raymond Chee Seong Seet
    Quek Wei Yong
    Tiong Cheng Yeo
    Boon Peng Lim
    [J]. Cardiovascular Drugs and Therapy, 2015, 29 : 187 - 197
12345